Cantuzumab mertansine

Jump to: navigation, search
Cantuzumab mertansine
Monoclonal antibody
Type?
SourceTemplate:Infobox drug/mab source
TargetCanAg
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Cantuzumab mertansine

Articles

Most recent articles on Cantuzumab mertansine

Most cited articles on Cantuzumab mertansine

Review articles on Cantuzumab mertansine

Articles on Cantuzumab mertansine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cantuzumab mertansine

Images of Cantuzumab mertansine

Photos of Cantuzumab mertansine

Podcasts & MP3s on Cantuzumab mertansine

Videos on Cantuzumab mertansine

Evidence Based Medicine

Cochrane Collaboration on Cantuzumab mertansine

Bandolier on Cantuzumab mertansine

TRIP on Cantuzumab mertansine

Clinical Trials

Ongoing Trials on Cantuzumab mertansine at Clinical Trials.gov

Trial results on Cantuzumab mertansine

Clinical Trials on Cantuzumab mertansine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cantuzumab mertansine

NICE Guidance on Cantuzumab mertansine

NHS PRODIGY Guidance

FDA on Cantuzumab mertansine

CDC on Cantuzumab mertansine

Books

Books on Cantuzumab mertansine

News

Cantuzumab mertansine in the news

Be alerted to news on Cantuzumab mertansine

News trends on Cantuzumab mertansine

Commentary

Blogs on Cantuzumab mertansine

Definitions

Definitions of Cantuzumab mertansine

Patient Resources / Community

Patient resources on Cantuzumab mertansine

Discussion groups on Cantuzumab mertansine

Patient Handouts on Cantuzumab mertansine

Directions to Hospitals Treating Cantuzumab mertansine

Risk calculators and risk factors for Cantuzumab mertansine

Healthcare Provider Resources

Symptoms of Cantuzumab mertansine

Causes & Risk Factors for Cantuzumab mertansine

Diagnostic studies for Cantuzumab mertansine

Treatment of Cantuzumab mertansine

Continuing Medical Education (CME)

CME Programs on Cantuzumab mertansine

International

Cantuzumab mertansine en Espanol

Cantuzumab mertansine en Francais

Business

Cantuzumab mertansine in the Marketplace

Patents on Cantuzumab mertansine

Experimental / Informatics

List of terms related to Cantuzumab mertansine


Overview

Cantuzumab mertansine is a humanized monoclonal antibody and which it's used to treat cancers. It has a chelator, mertansine.



Linked-in.jpg